US Stock MarketDetailed Quotes

RAPP Rapport Therapeutics

Watchlist

27.570
+2.570+10.28%

Close Jul 16 16:00 ET

1.01BMarket Cap-19013P/E (TTM)

Rapport Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Rapport Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

Revenue(YoY)

0.00

0.00%

EPS(YoY)

-0.94

-269.97%

Analyst Rating

Strong Buy

Jul 2, 2024

Rapport Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency:

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2024/Q3	-- / 0.000	--
--	2024/Q2	-- / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2024/Q3-- / 0.000--

--2024/Q2-- / 0.000--

--------

Unlock Free Earnings Estimates

Open Account

Analysis

Analyst Rating

Updated: Jul 2, 2024

Strong Buy

Buy
100.00%
Hold
0.00%
Sell
0.00%

Price Target

No Data

Overall